Experience with Sonidegib in Patients with Advanced Basal Cell Carcinoma: Case Reports

    May 2022 in “ Drugs in Context ”
    Susana Puig, C. Serra‐Guillén, Gemma Pérez‐Pastor … Ricardo Fernández‐de‐Misa Cabrera
    Studysummary This report describes the successful use of sonidegib in treating two cases of locally advanced basal cell carcinoma, leading to remission in both instances, and reducing lesions in a patient with Gorlin syndrome, while noting mild side effects consistent with the drug's known profile.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on drugsincontext.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma Journal of drugs in dermatology · 2021
    2. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma ˜The œoncologist · 2016

    Related research 1

    1. Managing Adverse Events Associated with Vismodegib in the Treatment of Basal Cell Carcinoma Future oncology · 2016